Search for: "John Glasscock" Results 1 - 20 of 27
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Oct 2018, 4:35 am by Brian Leiter
A longtime professor of philosophy at Texas A&M University, where he held the rank of Distinguished Professor and the Glasscock Chair in the Humanities, he was best-known for his work on classical American philosophy, including James and Dewey. [read post]
12 Mar 2013, 6:38 am by Broc Romanek
Delaware Denies Another Expedited Challenge John Grossbauer of Potter Anderson notes: In In re Bioclinica, Delaware Vice Chancellor Glasscock denied expedition in a challenge to the proposed sale of Bioclinica. [read post]
19 May 2023, 3:00 am by Meredith Ervine
VC Glasscock recently issued the seventh memorandum opinion in the litigation involving Oracle’s 2016 acquisition of NetSuite, which John has blogged about here previously. [read post]
23 Apr 2019, 6:27 am
Mar. 14, 2019), Vice Chancellor Glasscock of the Delaware Court of Chancery found that Rent-A-Center, Inc. [read post]
25 Jun 2019, 6:24 am
Posted by Amy Simmerman and John Aguirre, Wilson Sonsini Goodrich & Rosati, on Tuesday, June 25, 2019 Editor's Note: Amy Simmerman and John Aguirre are partners at Wilson Sonsini Goodrich & Rosati. [read post]
6 May 2019, 12:26 am by Peter Mahler
Some of you may recognize John’s name from posts on this blog or my interview of John on my podcast on various LLC issues–a topic on which John also is a top expert and author of the leading LLC formbook and practice manual entitled Drafting Limited Liability Company Operating Agreements also published by Wolters Kluwer. [read post]
14 Nov 2011, 7:02 am by Broc Romanek
Earnouts and Joint Ventures From John Grossbauer of Potter Anderson: In Coughlan v. [read post]
5 Dec 2008, 1:48 pm
Updating yesterday's ILB entry, John Russell of the Indianapolis Star reports today in a story headed "Locke Reynolds: new name, clout":Indianapolis is shaping up as Exhibit A in a new wave of mergers sweeping the legal industry. [read post]
22 Jun 2019, 7:14 am
 Related research from the Program on Corporate Governance includes M&A Contracts: Purposes, Types, Regulation, and Patterns of Practice and Allocating Risk Through Contract: Evidence from M&A and Policy Implications (discussed on the Forum here), both by John C. [read post]
22 Feb 2012, 12:46 am by Kevin LaCroix
”   Vice Chancellor Glasscock concluded that Hermelin had been successful in connection with the FDA matter, and therefore was entitled to mandatory indemnification for his fees in connection with that proceeding. [read post]
13 Sep 2011, 4:07 am by Broc Romanek
If the case survives, it should be interesting - as will the Citigroup case where discovery ended last week and now we're just waiting for a trial date to be set before VC Glasscock... [read post]
6 Sep 2021, 6:36 pm by Francis Pileggi
Vice Chancellor Sam Glasscock’s August 18 opinion allowed the motion to amend but only as to a new aiding and abetting charge not previously dismissed. [read post]
2 Sep 2020, 3:08 am by Liz Dunshee
This blog from Ann Lipton explains the case – and notes that unlike other recent Caremark claims, VC Glasscock appeared to be much more cautious in finding a “failure to monitor. [read post]
11 Oct 2015, 4:55 pm by Kevin LaCroix
In addition, at the roughly same time, Vice Chancellor John Noble withheld his approval of a shareholder settlement in a merger objection lawsuit arising from Roche’s $8.3 million acquisition of InterMune. [read post]
22 Dec 2015, 2:38 pm by Daniel Hemel
June 29, 2012), in which Vice Chancellor Sam Glasscock hewed closely to the reasoning in Freedman. [read post]